Pharmaceutical Buyers
Pharmaceutical Buyers, a leading entity in the pharmaceutical distribution sector, is headquartered in the United States, with significant operations across North America and Europe. Founded in the early 2000s, the company has established itself as a trusted partner for healthcare providers by offering a comprehensive range of pharmaceutical products and services. Specialising in the procurement and distribution of generic and branded medications, Pharmaceutical Buyers distinguishes itself through its commitment to quality and customer service. The company has achieved notable milestones, including strategic partnerships with major pharmaceutical manufacturers, enhancing its market position. With a focus on efficiency and reliability, Pharmaceutical Buyers continues to play a pivotal role in the healthcare supply chain, ensuring that essential medications are accessible to those in need.
DitchCarbon Score
How does Pharmaceutical Buyers's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Financial Intermediation industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmaceutical Buyers's score of 3 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Buyers's reported carbon emissions
Pharmaceutical Buyers, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints, often through various strategies such as improving energy efficiency, transitioning to renewable energy sources, and enhancing supply chain sustainability. As the industry evolves, it is expected that Pharmaceutical Buyers will align with these trends and establish measurable climate commitments in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmaceutical Buyers is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
